MA40170A - Dérivés hétérocycliques de morphinan et leur utilisation - Google Patents

Dérivés hétérocycliques de morphinan et leur utilisation

Info

Publication number
MA40170A
MA40170A MA040170A MA40170A MA40170A MA 40170 A MA40170 A MA 40170A MA 040170 A MA040170 A MA 040170A MA 40170 A MA40170 A MA 40170A MA 40170 A MA40170 A MA 40170A
Authority
MA
Morocco
Prior art keywords
heterocyclic
morphinan derivatives
morphinan
derivatives
solvates
Prior art date
Application number
MA040170A
Other languages
English (en)
Inventor
Laykea Tafesse
Mark A Youngman
Original Assignee
Purdue Pharma Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Pharma Lp filed Critical Purdue Pharma Lp
Publication of MA40170A publication Critical patent/MA40170A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La présente invention concerne des composés de formule (i) et des sels et solvates pharmaceutiquement acceptables de ceux-ci. Dans la formule (i), r
MA040170A 2014-06-13 2015-06-12 Dérivés hétérocycliques de morphinan et leur utilisation MA40170A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462011696P 2014-06-13 2014-06-13

Publications (1)

Publication Number Publication Date
MA40170A true MA40170A (fr) 2017-04-19

Family

ID=54834422

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040170A MA40170A (fr) 2014-06-13 2015-06-12 Dérivés hétérocycliques de morphinan et leur utilisation

Country Status (6)

Country Link
US (1) US10131666B2 (fr)
EP (1) EP3154971A4 (fr)
JP (2) JP2017521488A (fr)
CA (1) CA2952124A1 (fr)
MA (1) MA40170A (fr)
WO (1) WO2015192039A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014072809A2 (fr) 2012-11-09 2014-05-15 Purdue Pharma L.P. Analogues de benzomorphane et leur utilisation
WO2015097547A1 (fr) 2013-12-26 2015-07-02 Purdue Pharma L.P. Hydantoïnes de morphinane substitués en position 10
WO2015097548A1 (fr) 2013-12-26 2015-07-02 Purdue Pharma L.P. Analogues 7-bêta-alkyle d'orvinols
CA2934913A1 (fr) 2013-12-26 2015-07-02 Purdue Pharma L.P. Morphinanes a cycle contracte et leur utilisation
EP3087079B1 (fr) 2013-12-26 2019-04-03 Purdue Pharma LP Morphinanes oxabicyclo[2.2.2]octane modulateurs des récepteurs aux opiacés
US10550088B2 (en) 2013-12-27 2020-02-04 Purdue Pharma L.P. 6-substituted and 7-substituted morphinan analogs and the use thereof
CA2951697A1 (fr) 2014-06-13 2015-12-17 Purdue Pharma L.P. Derives d'azamophinan et leur utilisation
MA41125A (fr) 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation
CA3011182A1 (fr) 2016-01-13 2017-07-20 Grunenthal Gmbh Derives de 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane
EA034904B1 (ru) 2016-01-13 2020-04-03 Грюненталь Гмбх Производные 3-(карбоксиметил)-8-амино-2-оксо-1,3-диазаспиро-[4.5]-декана
ES2803354T3 (es) 2016-01-13 2021-01-26 Gruenenthal Gmbh Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decanodescripción
WO2017121647A1 (fr) 2016-01-13 2017-07-20 Grünenthal GmbH Dérivés de 3-((hétéro-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-décane
HUE049813T2 (hu) 2016-01-13 2020-10-28 Gruenenthal Gmbh 3-((hetero-)aril)-alkil-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-dekán származékok
WO2018125716A1 (fr) 2017-01-02 2018-07-05 Purdue Pharma L.P. Dérivés de morphinane et leur utilisation
TW201908295A (zh) 2017-07-12 2019-03-01 德商歌林達有限公司 １，３－二氮雜－螺－［３．４］－辛烷衍生物

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0496830T3 (da) 1989-10-16 1999-10-11 Us Health Total syntese af northebain, normorphin, noroxymorphonenantiomerer og derivater via N-nor-mellemprodukter
IT1270612B (it) * 1994-07-14 1997-05-07 Smithkline Beecham Farma Derivati eterociclo-condensatori di morfinoidi
AR005423A1 (es) * 1996-01-10 1999-06-23 Smithkline Beecham Spa Derivados morfinoides condensados con heterociclos (ii), su uso como sustancia terapeutica y para preparar medicamentos, composiciones farmaceuticasque los contienen y procedimiento para preparar dichos derivados.
BR9809288A (pt) 1997-04-22 2001-08-07 Cocensys Inc Semicarbazonas e tiosemicarbazonas substituìdas carbocìclicas e heterocìclicas e utilização das mesmas
MXPA00004919A (es) 1997-11-21 2002-10-17 Euro Celtique Sa 2-aminoacetamidas sustituidas y uso de las mismas.
US6281211B1 (en) 1999-02-04 2001-08-28 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
CN1353605A (zh) 1999-03-26 2002-06-12 欧洲凯尔特股份有限公司 芳基取代的吡唑、咪唑、噁唑、噻唑和吡咯及其应用
EP1169060B1 (fr) 1999-04-09 2005-08-31 Euro-Celtique S.A. Composition de blocage du canal sodique et leur utilisation
AR029489A1 (es) 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
CZ303632B6 (cs) 2000-03-24 2013-01-23 Euro-Celtique S.A. Arylem substituované pyrazoly, triazoly a tetrazoly a jejich pouzití
CN1426397A (zh) 2000-03-31 2003-06-25 欧洲凯尔特股份有限公司 氨基吡啶类化合物及其作为抗惊厥剂和钠通道阻滞剂的应用
JP2004538285A (ja) 2001-07-16 2004-12-24 ユーロ−セルティック エス． ア． アリール置換チアゾリジノンおよびその使用
AR036873A1 (es) 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
AR037233A1 (es) 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
EP1483247B1 (fr) 2002-03-13 2009-06-24 Euro-Celtique S.A. Pyrimidines substituees par aryle et utilisation associee
DE10229842A1 (de) 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
CN1671387A (zh) 2002-07-31 2005-09-21 欧洲凯尔特股份有限公司 芳基取代的乙内酰脲化合物及其作为钠通道阻滞剂的应用
CA2492305A1 (fr) 2002-07-31 2004-02-05 Euro-Celtique S.A. Benzimidazoles aryle substituees et utilisation de ce compose comme bloqueurs de canal
US20040152696A1 (en) 2002-08-01 2004-08-05 Euro-Celtique S.A. 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers
WO2005014849A2 (fr) 2003-07-03 2005-02-17 Euro-Celtique, S.A. Genes associes a des reponses a des douleurs neuropathiques
CN101481376A (zh) * 2008-01-10 2009-07-15 中国科学院上海药物研究所 一类杂环并14-羟基-吗啡喃类化合物、制备方法及用途
EP2582666B1 (fr) 2010-06-16 2014-08-13 Purdue Pharma L.P. Indoles à substitution aryle et leur utilisation en tant que bloqueur des canaux sodium
US9120752B2 (en) 2010-07-16 2015-09-01 Purdue Pharma, L.P. Pyridine compounds as sodium channel blockers
US9056832B2 (en) 2010-09-17 2015-06-16 Purdue Pharma L.P. Pyridine compounds and the users thereof
WO2012046132A1 (fr) 2010-10-05 2012-04-12 Purdue Pharma L.P. Composés de quinazoline en tant que bloqueurs de canaux sodiques
KR20130119964A (ko) 2010-12-22 2013-11-01 퍼듀 퍼머 엘피 나트륨 채널 차단제로서의 치환된 피리딘
PL2753606T3 (pl) 2011-09-02 2018-02-28 Purdue Pharma L.P. Pirymidyny jako blokery kanałów sodowych
WO2013064883A1 (fr) 2011-10-31 2013-05-10 Purdue Pharma L.P. Composés hétéroaryliques comme agents de blocage des canaux sodiques
WO2013064884A1 (fr) 2011-10-31 2013-05-10 Purdue Pharma L.P. Amines quaternisées en tant que bloqueurs des canaux sodiques
US9133131B2 (en) 2011-11-15 2015-09-15 Purdue Pharma L.P. Pyrimidine diol amides as sodium channel blockers
WO2013136170A1 (fr) 2012-03-16 2013-09-19 Purdue Pharma L.P. Pyridines substituées en tant que bloqueurs des canaux sodiques
CA2894963A1 (fr) * 2012-12-14 2014-06-19 Purdue Pharma L.P. Analogues de pyridonemorphinane et activite biologique sur des recepteurs des opioides
US8937084B2 (en) 2012-12-14 2015-01-20 Purdue Pharma L.P. Nitrogen containing morphinan derivatives and the use thereof
WO2014096941A1 (fr) 2012-12-20 2014-06-26 Purdue Pharma L.P. Sulfonamides cycliques en tant que bloquants des canaux sodiques
AU2014224310B2 (en) 2013-03-04 2017-02-09 Purdue Pharma L.P. Pyrimidine carboxamides as sodium channel blockers
US9120786B2 (en) 2013-03-04 2015-09-01 Purdue Pharma, L.P. Triazine carboxamides as sodium channel blockers
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
WO2014151393A2 (fr) 2013-03-15 2014-09-25 Purdue Pharma L.P. Dérivés de carboxamide et leur utilisation
AU2014270109B2 (en) 2013-05-24 2017-05-25 Rhodes Technologies Opioid ketal compounds and uses thereof
US9359330B2 (en) 2013-08-26 2016-06-07 Purdue Pharma L.P. Substituted piperidines as sodium channel blockers
US9828348B2 (en) 2013-11-08 2017-11-28 Purdue Pharma L.P. Benzimidazole derivatives and use thereof
US9340504B2 (en) 2013-11-21 2016-05-17 Purdue Pharma L.P. Pyridine and piperidine derivatives as novel sodium channel blockers
US9695144B2 (en) 2013-12-23 2017-07-04 Purdue Pharma L.P. Dibenzazepine derivatives and use thereof
WO2015102682A1 (fr) * 2013-12-30 2015-07-09 Purdue Pharma L.P. Analogues de morphinane pyridone-sulfones utilisés comme ligands de récepteurs opioïdes
CN106061944A (zh) 2014-01-24 2016-10-26 普渡制药公司 吡啶类和嘧啶类物质及其用途
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof

Also Published As

Publication number Publication date
US20180111934A1 (en) 2018-04-26
JP2017521488A (ja) 2017-08-03
WO2015192039A1 (fr) 2015-12-17
CA2952124A1 (fr) 2015-12-17
JP2019031519A (ja) 2019-02-28
EP3154971A4 (fr) 2017-11-01
US10131666B2 (en) 2018-11-20
EP3154971A1 (fr) 2017-04-19

Similar Documents

Publication Publication Date Title
MA40170A (fr) Dérivés hétérocycliques de morphinan et leur utilisation
MA40171A (fr) Dérivés d'azamophinan et leur utilisation
PH12019501321B1 (en) Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders
PH12016501972A1 (en) Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors
TW201613872A (en) IRAK4 inhibiting agents
AU2014267235A8 (en) Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
MX2017004200A (es) Compuestos de heteroarilo como inhibidores de tirosina-cinasa de bruton (btk) y usos de estos.
MA40058A (fr) Composés inhibiteurs de kinases se liant à tank
JO3317B1 (ar) مركبات تترا هيدروبيرولو ثيازين
MA39749A (fr) Dérivés de pipéridine-dione
MX2017003930A (es) Derivados de aminotriazina utiles como compuestos inhibidores de la cinasa de union a tank.
CR20150470A (es) Derivados de triazolona de piridinilo y piridinilo fusionado
MX2018001992A (es) Compuestos triciclicos heterociclicos como inhibidores de fosfoinositol 3-quinasa.
MX2018004664A (es) Antagonistas de ep4.
MA39866A (fr) Amides 2-amino-6-méthyl-4,4a,5,6-tétrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yle
MA40250A (fr) Dérivés de quinolizinone utilisés comme inhibiteurs de pi3k
JO3318B1 (ar) مثبطات bace
SA517381678B1 (ar) مركبات داي هيدرو بيريميدين-2-أون واستخدامها الطبي
MX2015013224A (es) Inhibidores macrociclicos y biciclicos del virus de la hepatitis c.
JOP20190163B1 (ar) منشط nrf2
EA201491227A1 (ru) Новые производные морфолинила, подходящие для применения в качестве ингибиторов mogat-2
IN2013MU03862A (fr)
EA201791099A1 (ru) Хинолин карбоксамиды для применения в лечении лейкоза
PH12016501645A1 (en) Aminopyrazolone derivative
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases